AMPLIURINA

This brand name is authorized in Ecuador.

Active ingredients

The drug AMPLIURINA contains a combination of these active pharmaceutical ingredients (APIs):

1	Ampicillin UNII 7C782967RD - AMPICILLIN
	Ampicillin is a broad spectrum penicillin, indicated for the treatment of a wide range of bacterial infections caused by ampicillin sensitive organisms.
	Read more about Ampicillin
2	Phenazopyridine UNII 0EWG668W17 - PHENAZOPYRIDINE HYDROCHLORIDE
	Phenazopyridine is excreted in the urine where it exerts a topical analgesic effect on the mucosa of the lower urinary tract. This action helps to relieve pain, burning, urgency and frequency. The precise mechanism of action is unknown.
	Read more about Phenazopyridine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CA51	Ampicillin, combinations	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CA Penicillins with extended spectrum
Discover more medicines within J01CA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	2406-MEN-0219, 27.479-1-09-11